The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Kirkcaldy, R. D., Harvey, A., Papp, J. R., del Rio, C., Soge, O. O., Holmes, K. K., Hook, E. W., Kubin, G., Riedel, S., Zenilman, J., et al. (2016) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6507a1 · Cited by 249
Mehta, S. D. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.2.124 · Cited by 58
Research works printed but not linked: 33
- Newman, 2015, Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PloS One, 10, e0143304, 10.1371/journal.pone.0143304 · DOI · Paper page
- Tramont, 1989, Gonococcal vaccines, Clin Microbiol Rev, 2, S74, 10.1128/CMR.2.Suppl.S74 · doi:10.1128/cmr.2.suppl.s74
- Lewis, 2014, Global resistance of Neisseria gonorrhoeae: when theory becomes reality, Curr Opin Infect Dis, 27, 62, 10.1097/QCO.0000000000000025 · doi:10.1097/qco.0000000000000025
- Bolan, 2012, The emerging threat of untreatable gonococcal infection, N Engl J Med, 366, 485, 10.1056/NEJMp1112456 · DOI · Paper page
- Edwards, 2016, Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development, Crit Rev Microbiol, 2, 928, 10.3109/1040841X.2015.1105782 · DOI
- Eyre, 1909, The treatment of gononcoccus infections by vaccines, Lancet, 174, 76, 10.1016/S0140-6736(01)32510-2 · doi:10.1016/s0140-6736(01)32510-2
- Greenberg, 1971, Preliminary studies on the development of a gonococcal vaccine, Bull World Health Organ, 45, 531
- Greenberg, 1974, Gonococcal vaccine studies in Inuvik, Can J Public Health, 65, 29
- Boslego, 1991, Efficacy trial of a parenteral gonococcal pilus vaccine in men, Vaccine, 9, 154, 10.1016/0264-410X(91)90147-X · DOI · Paper page
- Zhu, 2011, Vaccines for gonorrhea: can we rise to the challenge?, Front Microbiol, 2, 124, 10.3389/fmicb.2011.00124 · DOI
- Jerse, 2014, Vaccines against gonorrhea: Current status and future challenges, Vaccine, 32, 1579, 10.1016/j.vaccine.2013.08.067 · DOI
- Pérez, 2009, Mucosal approaches in Neisseria vaccinology, VacciMonitor, 18, 53
- Whelan, 2016, Ecologic study of meningococcal b vaccine and Neisseria gonorrhoeae infection, Norway, Emerg Infect Dis, 22, 1137, 10.3201/eid2206.151093 · doi:10.3201/eid2206.151093
- Holst, 2013, Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future, Hum Vaccin Immunother, 9, 1241, 10.4161/hv.24129 · DOI · Paper page
- Tinsley, 1996, Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: Two closely related bacteria expressing two different pathogenicities, Proc Natl Acad Sci USA, 93, 11, 10.1073/pnas.93.20.11109 · DOI · Paper page
- Arnold, 2011, Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand, Vaccine, 29, 7100, 10.1016/j.vaccine.2011.06.120 · DOI
- Wind, 2016, Time to clearance of Chlamydia trachomatis RNA and DNA after treatment in patients coinfected with Neisseria gonorrhoeae—a prospective cohort study, BMC Infect Dis, 16, 554, 10.1186/s12879-016-1878-3 · doi:10.1186/s12879-016-1878-3
- Clarivet, 2014, Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in asymptomatic patients under 30 years of age screened in a French sexually transmitted infections clinic, Eur J Dermatol, 24, 611, 10.1684/ejd.2014.2413 · doi:10.1684/ejd.2014.2413
- Weinberg, 2010, Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap, J Infect Dis, 201, 1607, 10.1086/652404 · DOI · Paper page
- Barnett, 2000, Holes in the safety net? Assessing the effects of targeted benefits upon the health care utilization of poor New Zealanders, Health Soc Care Community, 8, 159, 10.1046/j.1365-2524.2000.00239.x · doi:10.1046/j.1365-2524.2000.00239.x
- Manhart, 2004, Influence of study population on the identification of risk factors for sexually transmitted diseases using a case-control design: the example of gonorrhea, Am J Epidemiol, 160, 393, 10.1093/aje/kwh220 · DOI
- Virji, 2009, Pathogenic neisseriae: surface modulation, pathogenesis and infection control, Nat Rev Microbiol, 7, 274, 10.1038/nrmicro2097 · DOI · Paper page
- Rosenqvist, 1995, Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine, Infect Immun, 63, 4642, 10.1128/IAI.63.12.4642-4652.1995 · DOI · Paper page
- Davenport, 2003, Evidence for naturally acquired T cell mediated mucosal immunity to Neisseria meningitidis, J Immunol, 171, 4263, 10.4049/jimmunol.171.8.4263 · DOI
- Davenport, 2008, Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B, J Infect Dis, 198, 731, 10.1086/590669 · DOI
- Jackson, 2011, Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers, Arch Dis Childhood, 96, 744, 10.1136/adc.2009.180596 · DOI
- Bromhead, 2013, Comparison of the cobas 4800 CT/NG test with culture for detecting Neisseria gonorrhoeae in genital and nongenital specimens in a low-prevalence population in New Zealand, J Clin Microbiol, 51, 1505, 10.1128/JCM.03223-12 · doi:10.1128/jcm.03223-12
- Creighton, 2003, Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean?, Int J STD AIDS, 14, 109, 10.1258/095646203321156872 · DOI
- Vonck, 2011, Chlamydial infection increases gonococcal colonization in a novel murine coinfection model, Infect Immun, 79, 1566, 10.1128/IAI.01155-10 · DOI
- Hedges, 1998, Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections, J Infect Dis, 178, 742, 10.1086/515372 · DOI
- Comanducci, 2002, NadA, a novel vaccine candidate of Neisseria meningitidis, J Exper Med, 195, 1445, 10.1084/jem.20020407 · DOI · Paper page
- Hadad, 2012, Novel meningococcal 4CMenB vaccine antigens—prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae, APMIS, 120, 750, 10.1111/j.1600-0463.2012.02903.x · DOI
- Craig, 2015, The potential impact of vaccination on the prevalence of gonorrhea, Vaccine, 33, 4520, 10.1016/j.vaccine.2015.07.015 · doi:10.1016/j.vaccine.2015.07.015
Cited by
Cheng, K., Zhao, R., Li, Y., Qi, Y., Wang, Y., Zhang, Y., Qin, H., Qin, Y., Chen, L., Li, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22308-8 · Cited by 480
Biomimetic Nanotechnology toward Personalized Vaccines
Zhou, J., Kroll, A. V., Holay, M., Fang, R. H., & Zhang, L. (2020) · Advanced Materials · doi:10.1002/adma.201901255 · Cited by 328
The growing epidemic of sexually transmitted infections in adolescents: a neglected population
Shannon, C. L., & Klausner, J. D. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000578 · Cited by 298
Community-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
Li, Y., Zhao, R., Cheng, K., Zhang, K., Wang, Y., Zhang, Y., Li, Y., Liu, G., Xu, J., Xu, J., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03776 · Cited by 282
Metadata
- Authors
- Petousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., McArdle, B., Goodyear-Smith, F., & Black, S.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 390
- Issue
- 10102
- Pages
- 1603-1610
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2735393008
- Cited by
- 457
- References
- 3
- FWCI
- 32.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. https://app.cochat.ai/papers/10.1016/s0140-6736(17)31449-6
- The paper
- Petousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., McArdle, B., Goodyear-Smith, F., & Black, S. (2017). Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. The Lancet. https://doi.org/10.1016/s0140-6736(17)31449-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.